Anagenics Limited (ASX:AN1) Insider Acquires A$12,138.47 in Stock

Anagenics Limited (ASX:AN1) insider Alexander (Sandy) Beard acquired 1,734,067 shares of the company’s stock in a transaction dated Monday, May 5th. The shares were bought at an average cost of A$0.01 ($0.00) per share, with a total value of A$12,138.47 ($7,781.07).

Anagenics Price Performance

The company has a quick ratio of 1.15, a current ratio of 1.21 and a debt-to-equity ratio of 28.51. The firm has a market capitalization of $3.69 million, a PE ratio of -0.38 and a beta of -1.03.

Anagenics Company Profile

Anagenics Limited operates as a health and beauty tech company in Australia, New Zealand, and internationally. It develops and sells FGF5 inhibitor formulations; over-the-counter (OTC), cosmetic antiaging, and longevity targeting products; and imports and distributes international and local skin care and wellbeing products under the Thalgo, Hydro Peptide, Comfort Zone, Priori, and Inika Organic brand names.